Core Viewpoint - Medline's initial public offering (IPO) is set to be the largest of 2025, raising $6.26 billion and valuing the company at approximately $39 billion, despite a challenging economic environment for U.S. stock markets [12][13][14]. Company Overview - Medline is a medical supplies manufacturer based in Northfield, Illinois, founded in 1966 by brothers Jim and John Mills [2]. - The company produces around 335,000 different medical and surgical products, operating 33 global facilities and serving customers in over 100 countries [3]. Financial Performance - For the nine months ending September 27, Medline reported net sales of $20.6 billion and a net income of $977 million, compared to $18.7 billion in net sales and $911 million in net income for the same period the previous year [4]. IPO Details - Medline's IPO shares were priced at $29 each, at the higher end of the expected range of $26 to $30 [10]. - A total of 216,034,482 shares of Class A common stock were made available in the IPO [11]. - The IPO is expected to list on the Nasdaq Global Select Market under the ticker "MDLN" [9]. Historical Context - Medline has a history of public offerings, having originally gone public in 1972 before being taken private in 1977 [5]. - In 2021, a group of private equity investors acquired a majority stake in Medline for $34 billion, marking the largest leveraged buyout since the 2008 financial crisis [6]. Market Impact - Medline's IPO surpasses other significant IPOs in 2025, including the $5.3 billion raised by Contemporary Amperex Technology and the $1.75 billion raised by Venture Global [14].

Core Insights - Medline's shares surged 41% in their trading debut, closing at $41 after raising $6.26 billion in its IPO, marking one of the largest IPOs in recent years [1][4][7] Group 1: IPO Details - Medline sold over 216 million shares at $29 each, at the higher end of its anticipated range of $26 to $30 [2] - The proceeds from the IPO will be used to pay down some of the company's debts [2] Group 2: Financial Performance - For the first nine months of the year ending in September, Medline reported a net income of $977 million on revenue of $20.65 billion, an increase from $911 million on $18.72 billion in the same period the previous year [3] Group 3: Market Context - The IPO marks a recovery in the IPO market, although activity remains below the record levels seen in 2021 [4] - The $6.26 billion raised makes it the largest IPO since Rivian's $11.93 billion in 2021 [4] Group 4: Company Vision - CEO Jim Boyle stated that the IPO is expected to enhance Medline's brand, aiming to position the company as the "Costco of healthcare" for medical equipment buyers [5]

A group of shareholders in digital bank Monzo reportedly want to reinstate its outgoing CEO.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.TS Anil is due to step down as head of the U.K. company in February, but t ...

Core Viewpoint - Barrick Mining Corporation has resolved a long-standing dispute with the government of Mali, regaining control over the Loulo-Gounkoto gold asset after nearly two years of conflict and production halts [1][5]. Group 1: Dispute Background - The dispute originated in 2023 when Mali revised its mining code to increase state revenues through higher taxes and royalties [2]. - Tensions escalated through 2024 as Barrick resisted the changes, leading to audits and slowed export approvals, culminating in a court-ordered seizure of stockpiled gold in early 2025 [3]. Group 2: Resolution Details - In June, the Malian government took provisional control of the mine, detaining several Barrick employees and stalling negotiations [4]. - A breakthrough occurred last month when Barrick agreed to a financial settlement of approximately $430 million, leading to the release of detained employees and restoration of operational control [5]. Group 3: Financial Implications - Gold prices have surged over 55% year-to-date in 2025, with Loulo-Gounkoto producing between 700,000 and 725,000 ounces annually, translating to potential annual revenues exceeding $3 billion at current prices of over $4,300 per ounce [6]. - The resolution of the Mali situation alleviates significant geopolitical and operational uncertainties for Barrick, especially as gold prices reach record highs [7]. Group 4: Strategic Developments - The agreement enhances Barrick's strategic flexibility, potentially paving the way for a spinoff of its North American gold assets, which is currently under review [7][8]. - If the IPO proceeds, Barrick plans to separate premier assets into a standalone entity, aiming to unlock new shareholder value due to asset quality and jurisdiction safety [8].

Group 1 - HashKey's Initial Public Offering (IPO) raised HK$1.6 billion (approximately $206 million) by pricing its shares at HK$6.68, which is at the upper end of the proposed range [2][3] - On its first trading day, HashKey's shares opened at HK$6.7, peaked at HK$7.11, but ultimately closed at HK$6.51, reflecting a decline of around 3% by midday [1][2][3] - The IPO attracted nine prominent investors, including UBS AM Singapore, Fidelity, and CDH, indicating strong interest from institutional investors [3] Group 2 - HashKey's journey towards the IPO included clearing the HKEX listing hearing on December 1, which was a crucial step in the public listing process [4][5] - Following the hearing, HashKey engaged in prospectus registration, marketing, and book-building, aiming to raise $200 million in the IPO [5] - The Chairman and CEO of HashKey, Xiao Feng, emphasized the importance of compliance for long-term success and sustainable growth, viewing the listing as a starting point for greater responsibility [3]

Core Viewpoint - Medline Inc. has announced the pricing of its upsized initial public offering (IPO) of 216,034,482 shares of Class A common stock at a price of $29.00 per share, with trading expected to begin on December 17, 2025, under the symbol "MDLN" [1]. Group 1: IPO Details - The underwriters have been granted a 30-day option to purchase an additional 32,405,172 shares of Class A common stock [1]. - Medline plans to use the proceeds from the issuance of 179,000,000 shares to repay outstanding indebtedness under its senior secured term loan facilities, with the remainder allocated for general corporate purposes and offering expenses [1]. - The offering is expected to close on December 18, 2025, subject to customary closing conditions [1]. Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan are acting as global coordinators and lead bookrunning managers for the offering [2]. - A number of other financial institutions are involved as bookrunning managers and co-managers for the proposed offering [2]. Group 3: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care [5]. - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving healthcare providers' clinical, financial, and operational outcomes [5]. - Medline is headquartered in Northfield, Illinois, employs over 43,000 people worldwide, and operates in more than 100 countries [5].

Core Viewpoint - SpaceX is preparing for an Initial Public Offering (IPO), allowing public investment for the first time, which could mark a significant moment in economic history [1] Company Overview - SpaceX has operated as a private company, with shares held by a limited group of private investors and employees [3] - The company is now targeting a public listing that could value it at unprecedented levels, potentially rivaling major tech companies like Apple and Microsoft [4] Business Drivers - The success of Starlink, SpaceX's satellite internet business, has significantly increased the company's valuation, transforming it into a reliable revenue generator [2][5] - Starlink has become a dominant player in global telecommunications, providing internet services to millions in remote areas and various modes of transport [5] Financial Implications - Elon Musk, owning approximately 42% of SpaceX, could see his wealth increase dramatically with the IPO, potentially adding hundreds of billions to his net worth [6] - The IPO represents a shift in Musk's strategy, as he previously aimed to keep SpaceX private until achieving regular flights to Mars [7] Funding Needs - The decision to go public is driven by the need for substantial funding to support the ambitious projects, including the development of the Starship rocket and the expansion of Starlink [8] Market Expectations - The potential IPO is generating excitement among ordinary investors, who have long wished to invest in SpaceX [9] - Despite the high potential for profit, there are significant risks associated with space travel and Musk's leadership style, which could lead to stock price volatility [10][11] Future Outlook - No official date for the IPO has been set, but it is anticipated to occur in early 2026, with preparations underway in collaboration with major banks [13] - The successful IPO could not only reshape the stock market but also secure funding for future space exploration endeavors, indicating a shift towards serious business in the new space race [13]

It’s hard at first to grasp why Musk has suddenly become convinced that taking SpaceX public is worth the scrutiny, criticism, and regulatory burden he has long said he wanted to avoid. He was the leader who took Twitter private, after all, so he could instill sweeping layoffs and changes without the criticisms of the public markets. And, in earlier business history lore, he famously tweeted he was considering taking Tesla private in 2018—a tweet that prompted an SEC investigation and litigation with shareh ...

A fellow NYSE alum, incoming interim CFO Giviskos has served in her current role as Navan’s CAO and SVP, strategic finance since last June, according to the filing. Her previous roles include serving as chief risk and compliance officer for Euronext, as well as roles across a 10-year span at the NYSE beginning in 2004 — overlapping with Butte’s tenure as the exchange’s CFO which began that year.In association with her advisory seat, she is set to receive six months of her base salary, along with the prorate ...

Company Overview - Crane Harbor Acquisition Corp. II is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [2] - The company aims to identify acquisition opportunities primarily in the technology, real assets, and energy sectors [2] - The management team includes Jonathan Z. Cohen (Executive Chairman), Edward E. Cohen (Vice Chairman), William Fradin (CEO), Tom Elliott (CFO), and Jeffrey Brotman (Chief Legal Officer and COO) [2] Initial Public Offering (IPO) Details - The company announced the upsized pricing of its IPO, offering 30,000,000 units at a price of $10.00 per unit [1] - The units will be listed on the Nasdaq Global Market under the symbol "CRANU" and trading is set to begin on December 16, 2025 [1] - Each unit consists of one Class A ordinary share and one right to receive one fifteenth (1/15) of a Class A ordinary share upon the completion of the initial business combination [1] - The closing of the offering is anticipated to occur on or about December 17, 2025, subject to customary closing conditions [1] Underwriters and Legal Counsel - Cohen & Company Capital Markets acted as the lead book-running manager for the offering, with JonesTrading Institutional Services LLC as the joint book-runner [3] - Stevens & Lee, P.C. served as legal counsel to the company, while Kirkland & Ellis LLP acted as legal counsel to the underwriters [3] - The company has granted underwriters a 45-day option to purchase up to an additional 4,500,000 units at the IPO price to cover over-allotments [3] Regulatory Information - A registration statement for the units and underlying securities was declared effective by the Securities and Exchange Commission on December 15, 2025 [4] - The offering is being made only by means of a prospectus, which can be obtained from Cohen & Company Capital Markets [5]